Sampson J, Omuro A, Preusser M, Lim M, Butowski N, Cloughesy T, Strauss L, Latek R, Paliwal P, Weller M, Reardon D. A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498. Journal Of Clinical Oncology 2016, 34: tps2079-tps2079. DOI: 10.1200/jco.2016.34.15_suppl.tps2079.Peer-Reviewed Original Research